The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL

MLA

Annette V. Jacobsen, et al. “The Lck Inhibitor, AMG-47a, Blocks Necroptosis and Implicates RIPK1 in Signalling Downstream of MLKL.” Cell Death and Disease, vol. 13, no. 4, Apr. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41419-022-04740-w.

APA

Annette V. Jacobsen, Catia L. Pierotti, Kym N. Lowes, Amanda E. Au, Ying Zhang, Nima Etemadi, Cheree Fitzgibbon, Wilhelmus J. A. Kersten, André L. Samson, Mark F. van Delft, David C. S. Huang, Hélène Jousset Sabroux, Guillaume Lessene, John Silke, & James M. Murphy. (2022). The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL. Cell Death and Disease, 13(4), 1–13. https://doi.org/10.1038/s41419-022-04740-w

Chicago

Annette V. Jacobsen, Catia L. Pierotti, Kym N. Lowes, Amanda E. Au, Ying Zhang, Nima Etemadi, Cheree Fitzgibbon, et al. 2022. “The Lck Inhibitor, AMG-47a, Blocks Necroptosis and Implicates RIPK1 in Signalling Downstream of MLKL.” Cell Death and Disease 13 (4): 1–13. doi:10.1038/s41419-022-04740-w.